Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Torbjörn Fransson's publication output changed over time?
ScholarIQpublication output · 2010–2025
Output grew200% over the shown period — from 1 works in 2010 to 3 in 2025.
1
1
1
1
2
1
3
2010201820202022202320242025
What are the most-cited papers on Torbjörn Fransson?
ScholarIQmost cited works
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease
Joakim Nordanstig, Stefan James, Manne Andersson, Mattias Andersson, Peter Danielsson, Peter Gillgren, Martin Delle, Jan Engström, Torbjörn Fransson, Maher Hamoud, Anna Hilbertson, Patrik Johansson, Lars Karlsson, Björn Kragsterman, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Niklas Nyman, Henrik Renlund, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Asko Toivola, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Mårten Falkenberg
New England Journal of Medicine. 2020212 Citations
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial
Joakim Nordanstig, Stefan James, Manne Andersson, Mattias Andersson, Martin Delle, Jan Engström, Torbjörn Fransson, Peter Gillgren, Anna Hilbertson, Tal M. Hörer, Eva Jacobsson, Björn Kragsterman, Johan Lindbäck, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Olle Nelzén, Robert Olin, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Knut Thorbjørnsen, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Mårten Falkenberg
The Lancet. 202546 Citations
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
Mårten Falkenberg, Stefan James, Manne Andersson, Mattias Andersson, Martin Delle, Jan Engström, Torbjörn Fransson, Peter Gillgren, Anna Hilbertson, Tal M. Hörer, Eva Jacobsson, Björn Kragsterman, Johan Lindbäck, Hans Lindgren, Karin Ludwigs, Stefan Mellander, Olle Nelzén, Robert Olin, Birgitta Sigvant, Per Skoog, Joachim Starck, Gustaf Tegler, Knut Thorbjørnsen, Maria Truedson, Carl‐Magnus Wahlgren, Jonas Wallinder, Andreas Öjersjö, Joakim Nordanstig
The Lancet. 202533 Citations
Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial
Hans Lindgren, Peter Qvarfordt, Stefan Bergman, Anders Gottsäter, The Swedish Endovascular Claudication Stenting Trialists, Marianne Jansson, E. Litterfeldt, Hans Lindgren, Peter Qvarfordt, Torbjörn Fransson, Andreas Öjersjö, Anna Hilbertson, T. Röjlar, Anders Gottsäter, Gerald Gruber, Tal M. Hörer, Thomas Larzon, Torfi Jonasson, Charlotte Strandberg, Peter Andersson, Stefan Bergman, Lars Lundell, Anne-Marie Svensson, M. Warvsten
CardioVascular and Interventional Radiology. 201817 CitationsOPEN ACCESS
Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial
Torbjörn Fransson, Anders Gottsäter, Mohammad Abdulrasak, Martin Malina, Timothy Resch
Journal of International Medical Research. 202215 CitationsOPEN ACCESS
Related on ScholarIQ
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease
Paper
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial
Paper
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
Paper
Primary Stenting of the Superficial Femoral Artery in Patients with Intermittent Claudication Has Durable Effects on Health-Related Quality of Life at 24 Months: Results of a Randomized Controlled Trial
Paper
Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial
Paper
In situ saphenous vein bypass grafting - still first line treatment? A prospective study comparing surgical results between diabetic and non-diabetic populations
Paper